CRP and Hypocalcemia: Laboratory findings during the active phase of CTB revealed statistically significant elevations in C-reactive protein levels (P = 0.001), thrombocytopenia (P = 0.007), hyponatremia (P = 0.040), hypocalcemia (P = 0.022), and hypomagnesemia (P = 0.025).